GeneNews Ltd. (TSE:GEN) remained flat at $0.13 during midday trading on Thursday. 335,600 shares of the company’s stock were exchanged. GeneNews Ltd. has a one year low of $0.13 and a one year high of $0.57. The company’s market capitalization is $11.43 million. The firm has a 50-day moving average price of $0.16 and a 200 day moving average price of $0.27.
TRADEMARK VIOLATION WARNING: This piece was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/2797514/genenews-ltd-gen-set-to-announce-quarterly-earnings-on-tuesday.html.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Receive News & Ratings for GeneNews Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.